Andrew T. Kaplan (Kailera Therapeutics, Inc.) Insider Trades | Tormere

Andrew T. Kaplan

Director

Director at Kailera Therapeutics, Inc., filing insider transactions on 2026-04-20.

Total Purchases

$134.4M

1 transaction

Total Sales

—

0 transactions

Companies Traded

1

1 total filings

Active Since

2026-04-20

Last: 2026-04-20

Companies

Kailera Therapeutics, Inc.

↑ $134.4M (1)

Other Reporting Insiders at Kailera Therapeutics, Inc.

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-04-20	KLRA	Purchase	8.40M	$16.00	$134.4M	26.26M	SEC ↗